Galecto Biotech (private company)

See something wrong or missing? Let us know
Offices:Copenhagen
Business model:B2B

Galecto Biotech AB develops galectin modulators for the treatment of severe diseases, including fibrosis, cancer and inflammation

Investors: we tracked 11 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 153.64M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Galecto Biotech

Name Criteria
Germany Atai Life Sciences
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 6
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Sweden BoneSupport
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany CatalYm
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom LabGenius
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Denmark MedTrace
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Denmark MinervaX
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 6
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Denmark Muna Therapeutics
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom Ori Biotech
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Netherlands Salvia BioElectronics
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 5
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Top